Published in J Am Acad Dermatol on November 01, 2000
Pharmacologic interventions in aging hair. Clin Interv Aging (2006) 1.20
Female pattern hair loss: current treatment concepts. Clin Interv Aging (2007) 1.02
Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol (2014) 0.97
Female pattern alopecia: current perspectives. Int J Womens Health (2013) 0.95
Female pattern hair loss. Int J Endocrinol Metab (2013) 0.84
Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study. Br J Dermatol (2012) 0.82
Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women. Int J Trichology (2013) 0.82
The Diagnosis and Treatment of Hair and Scalp Diseases. Dtsch Arztebl Int (2016) 0.81
Direct-to-consumer advertising. Finasteride for male pattern hair loss. Can Fam Physician (2001) 0.79
Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. J Clin Aesthet Dermatol (2016) 0.78
Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases. Oncotarget (2016) 0.77
Cross-section Trichometry: A Clinical Tool for Assessing the Progression and Treatment Response of Alopecia. Int J Trichology (2012) 0.77
Efficacy of Finasteride 1.25 mg on Female Pattern Hair Loss; Pilot Study. Ann Dermatol (2012) 0.76
Contraindicated use of 5-alpha-reductase inhibitors in women. Br J Clin Pharmacol (2016) 0.75
Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems. Int J Mol Sci (2017) 0.75
Hormonal therapy in female pattern hair loss. Int J Womens Dermatol (2017) 0.75
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med (1998) 6.44
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med (1999) 4.35
Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron (1990) 4.15
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol (1996) 3.09
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr (1997) 2.92
Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell (2000) 2.70
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol (1998) 2.68
ENDOSPORE FORMATION BY BACILLUS SUBTILIS IN A SYNTHETIC MEDIUM. Science (1934) 2.63
Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology (1999) 2.41
Randomized multicenter trial comparing synchronized and conventional intermittent mandatory ventilation in neonates. J Pediatr (1996) 2.35
Mutation of a Locus of Arabidopsis thaliana Confers Resistance to the Herbicide Isoxaben. Plant Physiol (1989) 2.35
A new look at scarring alopecia. Arch Dermatol (2000) 2.26
Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron (1999) 2.15
Steps involved in the processing of common precursor forms of adrenocorticotropin and endorphin in cultures of mouse pituitary cells. Biochemistry (1978) 2.08
Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol (1999) 2.02
Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes (1998) 1.98
Characterization of a common precursor to corticotropin and beta-lipotropin: cell-free synthesis of the precursor and identification of corticotropin peptides in the molecule. Proc Natl Acad Sci U S A (1977) 1.93
Characterization of a common precursor to corticotropin and beta-lipotropin: identification of beta-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell-free system. Proc Natl Acad Sci U S A (1977) 1.81
Structural abnormalities of the hair shaft. J Am Acad Dermatol (1987) 1.75
Management of the infected median sternotomy wound with muscle flaps. The Emory 20-year experience. Ann Surg (1997) 1.72
A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A (2006) 1.69
Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol (1999) 1.67
A Second Locus, Ixr B1 in Arabidopsis thaliana, that Confers Resistance to the Herbicide Isoxaben. Plant Physiol (1990) 1.61
Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol Cell (2001) 1.61
Expression of cloned beta-endorphin gene sequences by Escherichia coli. Nature (1980) 1.59
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology (2002) 1.58
CT of congenital and acquired abnormalities of the spleen. Radiographics (1993) 1.54
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab (1992) 1.51
Abnormal nevoblast migration mimicking neurofibromatosis. Arch Dermatol (1991) 1.51
Corticotropin and beta-endorphin: construction and analysis of recombinant DNA complementary to mRNA for the common precursor. Proc Natl Acad Sci U S A (1979) 1.49
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol (2000) 1.47
Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med (1980) 1.47
Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology (1999) 1.43
Long-term results of surgery for lithium-associated hyperparathyroidism. Br J Surg (2010) 1.43
Molecular cloning and primary structure of rat testes metalloendopeptidase EC 3.4.24.15. Biochemistry (1990) 1.35
Risk factors for vesicourethral anastomotic stricture after radical prostatectomy. Urology (2000) 1.33
In situ hybridization histochemistry: a technique for the study of gene expression in single cells. DNA (1983) 1.32
Auditory brainstem responses in preterm neonates: maturation and follow-up. J Pediatr (1982) 1.29
Food borne infection by a Norwalk like virus (small round structured virus). J Clin Pathol (1984) 1.29
Stoichiometry of the T cell antigen receptor (TCR) complex: each TCR/CD3 complex contains one TCR alpha, one TCR beta, and two CD3 epsilon chains. J Exp Med (1994) 1.28
Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol (1998) 1.27
Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) (1978) 1.25
Identification of proopiomelanocortin neurones in rat hypothalamus by in situ cDNA-mRNA hybridization. Nature (1984) 1.24
Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol (1999) 1.24
Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary. J Biol Chem (1984) 1.24
Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology (2001) 1.19
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group. Urology (2000) 1.19
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol (1999) 1.18
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials. Eur Urol (2000) 1.17
Regulation of proopiomelanocortin gene expression in pituitary. Endocr Rev (1988) 1.17
Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei. Science (1986) 1.17
Topical minoxidil in early male pattern baldness. J Am Acad Dermatol (1985) 1.16
Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol (2001) 1.16
Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database. Intern Med J (2007) 1.15
Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol Endocrinol (1992) 1.14
Topical minoxidil in male pattern baldness: effects of discontinuation of treatment. J Am Acad Dermatol (1987) 1.12
Diazepam binding inhibitor gene expression: location in brain and peripheral tissues of rat. Proc Natl Acad Sci U S A (1988) 1.12
Treatment of erythema nodosum and nodular vasculitis with potassium iodide. Br J Dermatol (1976) 1.11
TCR alpha-CD3 delta epsilon association is the initial step in alpha beta dimer formation in murine T cells and is limiting in immature CD4+ CD8+ thymocytes. Immunity (1995) 1.11
In situ cDNA:mRNA hybridization: development of a technique to measure mRNA levels in individual cells. Methods Enzymol (1986) 1.10
Ocular immune reactants in patients dying with systemic lupus erythematosus. Clin Immunol Immunopathol (1985) 1.09
Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group. Eur Urol (2000) 1.09
Active bacterial luciferase from a fused gene: expression of a Vibrio harveyi luxAB translational fusion in bacteria, yeast and plant cells. Gene (1989) 1.09
Erosion of psoriatic plaques after chronic methotrexate administration. Int J Dermatol (1988) 1.09
The proopiocortin (adrenocorticotropin/beta-lipoprotein) gene is located on chromosome 2 in humans. Somatic Cell Genet (1981) 1.08
Regulation of immunoglobulin synthesis by dextran. J Exp Med (1973) 1.07
Topical clobetasol-17-propionate: review of its clinical efficacy and safety. J Am Acad Dermatol (1986) 1.07
Committee on Administrative Practice : Report of the Committee. Am J Public Health Nations Health (1928) 1.07
Cooperation among multiple transcription factors is required for access to minimal T-cell receptor alpha-enhancer chromatin in vivo. Mol Cell Biol (1998) 1.06
Treatment of chromoblastomycosis with high local concentrations of amphotericin B. Br J Dermatol (1967) 1.06
Identification of antinative DNA antibodies in cryoglobulinemic states. Am J Med (1978) 1.04
Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res (1996) 1.04
Developmental regulation of V(D)J recombination at the TCR alpha/delta locus. Immunol Rev (1998) 1.03
Management of primary cicatricial alopecias: options for treatment. Br J Dermatol (2008) 1.03
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis. Antimicrob Agents Chemother (2009) 1.02
Circulating immune complex assays in patients with lupus and membranous glomerulonephritis. Clin Immunol Immunopathol (1979) 1.02
Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. Proc Natl Acad Sci U S A (1983) 1.02
Pharyngeal airway obstruction in preterm infants during mixed and obstructive apnea. J Pediatr (1982) 1.02
Selective reduction of proadrenocorticotropin/endorphin proteins and messenger ribonucleic acid activity in mouse pituitary tumor cells by glucocorticoids. Biochemistry (1979) 1.02